Population
15 monoclonal antibodies made to coxsackievirus B-3, tested against a panel of enteroviruses and 45 clinical…
Design
Preclinical
Authors
Loading...
These MAbs merit further diagnostic evaluation; leaves open clinical adoption pending human validation studies.
Monoclonal antibodies to coxsackievirus B-3 show varying specificities and may serve as diagnostic reagents for grouping and typing enteroviruses.
Yagi et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: